Do analysts prefer EUDA or DOUG?

EUDA Health currently has a consensus price target of $55.00, suggesting a potential upside of 209.06%. Given EUDA Health's stronger consensus rating and higher probable upside, research analysts clearly believe EUDA Health is more favorable than Douglas Elliman. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Douglas Elliman 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, EUDA or DOUG?

Douglas Elliman has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M 7.80 -$2.77M N/A N/A Douglas Elliman $1.03B 0.14 $15.22M $0.17 9.21

Does the media prefer EUDA or DOUG?

In the previous week, EUDA Health and EUDA Health both had 1 articles in the media. Douglas Elliman's average media sentiment score of 0.20 beat EUDA Health's score of -0.95 indicating that Douglas Elliman is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Douglas Elliman 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, ASPS or EUDA?

Altisource Portfolio Solutions has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Altisource Portfolio Solutions $170.98M 0.38 $1.62M -$0.99 N/A EUDA Health $6.82M 7.80 -$2.77M N/A N/A

Do analysts rate EUDA or DUO?

EUDA Health presently has a consensus target price of $55.00, indicating a potential upside of 209.06%. Given EUDA Health's stronger consensus rating and higher probable upside, analysts clearly believe EUDA Health is more favorable than Fangdd Network Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Fangdd Network Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, EUDA or DUO?

EUDA Health has higher earnings, but lower revenue than Fangdd Network Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio EUDA Health $6.82M 7.80 -$2.77M N/A N/A Fangdd Network Group $50.74M 0.48 -$12.11M N/A N/A

Is EUDA or DUO more profitable?

Company Net Margins Return on Equity Return on Assets EUDA Health N/A N/A N/A Fangdd Network Group N/A N/A N/A

Which has stronger earnings & valuation, FTHM or EUDA?

EUDA Health has lower revenue, but higher earnings than Fathom. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fathom $420.48M 0.02 -$20.31M -$0.80 N/A EUDA Health $6.82M 7.80 -$2.77M N/A N/A

Is FTHM or EUDA more profitable?

EUDA Health has a net margin of 0.00% compared to Fathom's net margin of -6.27%. EUDA Health's return on equity of 0.00% beat Fathom's return on equity. Company Net Margins Return on Equity Return on Assets Fathom -6.27% -75.89% -33.25% EUDA Health N/A N/A N/A

Does the media favor FTHM or EUDA?

In the previous week, Fathom had 4 more articles in the media than EUDA Health. MarketBeat recorded 5 mentions for Fathom and 1 mentions for EUDA Health. Fathom's average media sentiment score of 0.51 beat EUDA Health's score of -0.95 indicating that Fathom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fathom 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative

Do analysts recommend LHAI or EUDA?

EUDA Health has a consensus price target of $55.00, indicating a potential upside of 209.06%. Given EUDA Health's stronger consensus rating and higher probable upside, analysts plainly believe EUDA Health is more favorable than Linkhome. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Linkhome 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation and earnings, LHAI or EUDA?

Linkhome has higher revenue and earnings than EUDA Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Linkhome $20.99M 0.81 $70K -$0.03 N/A EUDA Health $6.82M 7.80 -$2.77M N/A N/A

Does the media prefer LHAI or EUDA?

In the previous week, Linkhome and Linkhome both had 1 articles in the media. Linkhome's average media sentiment score of 0.54 beat EUDA Health's score of -0.95 indicating that Linkhome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Linkhome 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EUDA Health 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative

EUDA Health (EUDA) Competitors

$18.02 -0.58 (-3.10%)

Closing price 03:58 PM Eastern

Extended Trading

$17.75 -0.27 (-1.52%)

As of 04:04 PM Eastern

Compare

EUDA vs. DOUG, ASPS, DUO, FTHM, and LHAI

Should you buy EUDA Health stock or one of its competitors? EUDA Health's main competitors and comparable companies include Douglas Elliman (DOUG), Altisource Portfolio Solutions (ASPS), Fangdd Network Group (DUO), Fathom (FTHM), and Linkhome (LHAI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "real estate services" industry.

How does EUDA Health compare to Douglas Elliman?

EUDA Health (NASDAQ:EUDA) and Douglas Elliman (NYSE:DOUG) are both small-cap real estate companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

In the previous week, EUDA Health and EUDA Health both had 1 articles in the media. Douglas Elliman's average media sentiment score of 0.20 beat EUDA Health's score of -0.95 indicating that Douglas Elliman is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Douglas Elliman	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 59.6% of Douglas Elliman shares are held by institutional investors. 9.6% of Douglas Elliman shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

EUDA Health has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Douglas Elliman has a beta of 1.89, suggesting that its share price is 89% more volatile than the broader market.

EUDA Health currently has a consensus price target of $55.00, suggesting a potential upside of 209.06%. Given EUDA Health's stronger consensus rating and higher probable upside, research analysts clearly believe EUDA Health is more favorable than Douglas Elliman.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Douglas Elliman	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Douglas Elliman has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	7.80	-$2.77M	N/A	N/A
Douglas Elliman	$1.03B	0.14	$15.22M	$0.17	9.21

Douglas Elliman has a net margin of 2.47% compared to EUDA Health's net margin of 0.00%. EUDA Health's return on equity of 0.00% beat Douglas Elliman's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Douglas Elliman	2.47%	-19.16%	-6.72%

Summary

Douglas Elliman beats EUDA Health on 7 of the 13 factors compared between the two stocks.

How does EUDA Health compare to Altisource Portfolio Solutions?

Altisource Portfolio Solutions (NASDAQ:ASPS) and EUDA Health (NASDAQ:EUDA) are both small-cap real estate companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

Altisource Portfolio Solutions presently has a consensus price target of $8.00, suggesting a potential upside of 40.35%. EUDA Health has a consensus price target of $55.00, suggesting a potential upside of 209.06%. Given EUDA Health's higher probable upside, analysts plainly believe EUDA Health is more favorable than Altisource Portfolio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Altisource Portfolio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Altisource Portfolio Solutions has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Altisource Portfolio Solutions	$170.98M	0.38	$1.62M	-$0.99	N/A
EUDA Health	$6.82M	7.80	-$2.77M	N/A	N/A

41.4% of Altisource Portfolio Solutions shares are held by institutional investors. Comparatively, 4.4% of EUDA Health shares are held by institutional investors. 19.1% of Altisource Portfolio Solutions shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Altisource Portfolio Solutions has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, EUDA Health has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

EUDA Health has a net margin of 0.00% compared to Altisource Portfolio Solutions' net margin of -5.93%. EUDA Health's return on equity of 0.00% beat Altisource Portfolio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Altisource Portfolio Solutions	-5.93%	-1.69%	1.31%
EUDA Health	N/A	N/A	N/A

In the previous week, EUDA Health had 1 more articles in the media than Altisource Portfolio Solutions. MarketBeat recorded 1 mentions for EUDA Health and 0 mentions for Altisource Portfolio Solutions. Altisource Portfolio Solutions' average media sentiment score of 1.17 beat EUDA Health's score of -0.95 indicating that Altisource Portfolio Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Altisource Portfolio Solutions	Positive
EUDA Health	Negative

Summary

Altisource Portfolio Solutions beats EUDA Health on 8 of the 15 factors compared between the two stocks.

How does EUDA Health compare to Fangdd Network Group?

EUDA Health (NASDAQ:EUDA) and Fangdd Network Group (NASDAQ:DUO) are both small-cap real estate companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

EUDA Health has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market. Comparatively, Fangdd Network Group has a beta of 3.22, indicating that its share price is 222% more volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Fangdd Network Group	N/A	N/A	N/A

4.4% of EUDA Health shares are held by institutional investors. 35.2% of Fangdd Network Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, EUDA Health had 1 more articles in the media than Fangdd Network Group. MarketBeat recorded 1 mentions for EUDA Health and 0 mentions for Fangdd Network Group. Fangdd Network Group's average media sentiment score of 0.00 beat EUDA Health's score of -0.95 indicating that Fangdd Network Group is being referred to more favorably in the news media.

Company	Overall Sentiment
EUDA Health	Negative
Fangdd Network Group	Neutral

EUDA Health has higher earnings, but lower revenue than Fangdd Network Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82M	7.80	-$2.77M	N/A	N/A
Fangdd Network Group	$50.74M	0.48	-$12.11M	N/A	N/A

EUDA Health presently has a consensus target price of $55.00, indicating a potential upside of 209.06%. Given EUDA Health's stronger consensus rating and higher probable upside, analysts clearly believe EUDA Health is more favorable than Fangdd Network Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Fangdd Network Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

EUDA Health beats Fangdd Network Group on 7 of the 11 factors compared between the two stocks.

How does EUDA Health compare to Fathom?

Fathom (NASDAQ:FTHM) and EUDA Health (NASDAQ:EUDA) are both small-cap real estate companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

EUDA Health has a net margin of 0.00% compared to Fathom's net margin of -6.27%. EUDA Health's return on equity of 0.00% beat Fathom's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fathom	-6.27%	-75.89%	-33.25%
EUDA Health	N/A	N/A	N/A

In the previous week, Fathom had 4 more articles in the media than EUDA Health. MarketBeat recorded 5 mentions for Fathom and 1 mentions for EUDA Health. Fathom's average media sentiment score of 0.51 beat EUDA Health's score of -0.95 indicating that Fathom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fathom	0 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Fathom presently has a consensus target price of $2.50, suggesting a potential upside of 1,031.73%. EUDA Health has a consensus target price of $55.00, suggesting a potential upside of 209.06%. Given Fathom's stronger consensus rating and higher probable upside, research analysts plainly believe Fathom is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fathom	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Fathom has a beta of 2.25, meaning that its stock price is 125% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

EUDA Health has lower revenue, but higher earnings than Fathom.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fathom	$420.48M	0.02	-$20.31M	-$0.80	N/A
EUDA Health	$6.82M	7.80	-$2.77M	N/A	N/A

55.5% of Fathom shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 16.4% of Fathom shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Fathom beats EUDA Health on 9 of the 15 factors compared between the two stocks.

How does EUDA Health compare to Linkhome?

Linkhome (NASDAQ:LHAI) and EUDA Health (NASDAQ:EUDA) are both small-cap real estate companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

EUDA Health has a consensus price target of $55.00, indicating a potential upside of 209.06%. Given EUDA Health's stronger consensus rating and higher probable upside, analysts plainly believe EUDA Health is more favorable than Linkhome.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Linkhome	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Linkhome has higher revenue and earnings than EUDA Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Linkhome	$20.99M	0.81	$70K	-$0.03	N/A
EUDA Health	$6.82M	7.80	-$2.77M	N/A	N/A

In the previous week, Linkhome and Linkhome both had 1 articles in the media. Linkhome's average media sentiment score of 0.54 beat EUDA Health's score of -0.95 indicating that Linkhome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Linkhome	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EUDA Health	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

EUDA Health has a net margin of 0.00% compared to Linkhome's net margin of -2.83%. EUDA Health's return on equity of 0.00% beat Linkhome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Linkhome	-2.83%	-7.86%	-6.68%
EUDA Health	N/A	N/A	N/A

Linkhome has a beta of -0.07, indicating that its share price is 107% less volatile than the broader market. Comparatively, EUDA Health has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

4.4% of EUDA Health shares are owned by institutional investors. 31.2% of Linkhome shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

EUDA Health beats Linkhome on 9 of the 13 factors compared between the two stocks.

Get EUDA Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EUDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EUDA vs. The Competition

Export

Metric	EUDA Health	Real Estate Management & Development Industry	Real Estate Sector	NASDAQ Exchange
Market Cap	$53.89M	$2.99B	$5.15B	$13.28B
Dividend Yield	N/A	4.70%	6.62%	16.36%
P/E Ratio	N/A	13.75	27.32	26.17
Price / Sales	7.90	83.88	118.79	97.38
Price / Cash	N/A	19.25	33.91	53.72
Price / Book	-7.98	1.93	1.74	6.34
Net Income	-$2.77M	-$444.06M	-$73.72M	$381.90M
7 Day Performance	4.55%	-0.07%	-0.40%	-1.38%
1 Month Performance	37.59%	-4.13%	-4.18%	-4.30%
1 Year Performance	-67.11%	-13.28%	3.78%	-0.35%

EUDA Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EUDA EUDA Health	2.9276 of 5 stars	$18.02 -3.1%	$55.00 +205.1%	-65.5%	$53.89M	$6.82M	N/A	123	Gap Down
DOUG Douglas Elliman	1.4849 of 5 stars	$1.53 +0.3%	N/A	-44.9%	$138.15M	$1.03B	8.97	580
ASPS Altisource Portfolio Solutions	4.1142 of 5 stars	$6.69 +9.5%	$8.00 +19.6%	-57.1%	$69.78M	$182.50M	N/A	1,236	High Trading Volume
DUO Fangdd Network Group	0.6343 of 5 stars	$0.62 -2.4%	N/A	-83.8%	$24.56M	$50.74M	N/A	144
FTHM Fathom	3.2968 of 5 stars	$0.44 -12.6%	$2.50 +474.3%	-87.2%	$17.03M	$420.48M	N/A	281	Positive News Short Interest Increase Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EUDA) was last updated on 10/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EUDA Health (EUDA) Competitors

EUDA vs. DOUG, ASPS, DUO, FTHM, and LHAI

How does EUDA Health compare to Douglas Elliman?

Summary

How does EUDA Health compare to Altisource Portfolio Solutions?

Summary

How does EUDA Health compare to Fangdd Network Group?

Summary

How does EUDA Health compare to Fathom?

Summary

How does EUDA Health compare to Linkhome?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

EUDA Health (EUDA) Competitors

EUDA vs. DOUG, ASPS, DUO, FTHM, and LHAI

How does EUDA Health compare to Douglas Elliman?

Does the media prefer EUDA or DOUG?

Do insiders & institutionals hold more shares of EUDA or DOUG?

Which has more volatility and risk, EUDA or DOUG?

Do analysts prefer EUDA or DOUG?

Which has preferable valuation & earnings, EUDA or DOUG?

Is EUDA or DOUG more profitable?

Summary

How does EUDA Health compare to Altisource Portfolio Solutions?

Do analysts rate ASPS or EUDA?

Which has better valuation and earnings, ASPS or EUDA?

Do insiders and institutionals have more ownership in ASPS or EUDA?

Which has more volatility and risk, ASPS or EUDA?

Is ASPS or EUDA more profitable?

Does the media favor ASPS or EUDA?

Summary

How does EUDA Health compare to Fangdd Network Group?

Which has more volatility & risk, EUDA or DUO?

Is EUDA or DUO more profitable?

Do insiders & institutionals believe in EUDA or DUO?

Does the media refer more to EUDA or DUO?

Which has better valuation and earnings, EUDA or DUO?

Do analysts rate EUDA or DUO?

Summary

How does EUDA Health compare to Fathom?

Is FTHM or EUDA more profitable?

Does the media favor FTHM or EUDA?

Do analysts prefer FTHM or EUDA?

Which has more volatility & risk, FTHM or EUDA?

Which has stronger earnings & valuation, FTHM or EUDA?

Do institutionals & insiders have more ownership in FTHM or EUDA?

Summary

How does EUDA Health compare to Linkhome?

Do analysts recommend LHAI or EUDA?

Which has stronger valuation and earnings, LHAI or EUDA?

Does the media prefer LHAI or EUDA?

Is LHAI or EUDA more profitable?

Which has more volatility & risk, LHAI or EUDA?

Do institutionals and insiders believe in LHAI or EUDA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EUDA vs. The Competition

EUDA Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools